1. Current frontline endocrine treatment options for women with hormone receptor-positive, Human Epidermal Growth Factor Receptor 2 (HER2)-negative advanced-stage breast cancer;Abdel-Razeq;Hematol. Oncol. Stem Cell Ther.,2018
2. Combating breast cancer with non-steroidal aromatase inhibitors (NSAIs): Understanding the chemico-biological interactions through comparative SAR/QSAR study;Adhikari;Eur. J. Med. Chem.,2017
3. Overcoming endocrine resistance in hormone receptor-positive breast cancer;AlFakeeh;Curr Oncol.,2018
4. Ali S, Rasool M, Chaoudhry H, P NP, Jha P, Hafiz A, Mahfooz M, Abdus Sami G, Azhar Kamal M, Bashir S et al. 2016. Molecular mechanisms and mode of tamoxifen resistance in breast cancer. Bioinformation. 12(3):135-139. eng.
5. Aromatase inhibitors in breast cancer: an overview;Altundag;Oncologist,2006